These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9315418)

  • 21. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the action of nonoxynol-9 and chlorhexidine on sperm.
    Sharman D; Chantler E; Dukes M; Hutchinson FG; Elstein M
    Fertil Steril; 1986 Feb; 45(2):259-64. PubMed ID: 3005050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative spermicidal performance of iodinated and non-iodinated contraceptive formulations of nonoxynol-9 co-precipitated with polyvinylpyrrolidone.
    Zavos PM; Correa JR; Nosek D; Mohammadi F; Digenis GA
    Contraception; 1996 Jul; 54(1):39-41. PubMed ID: 8804807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro spermicidal activity of chelating agents and synergistic effect with nonoxynol-9 on human sperm functionality.
    Lee CH; Bagdon R; Chien YW
    J Pharm Sci; 1996 Jan; 85(1):91-5. PubMed ID: 8926592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal contraception with gossypol: a clinical study.
    Ratsula K; Haukkamaa M; Wichmann K; Luukkainen T
    Contraception; 1983 Jun; 27(6):571-6. PubMed ID: 6684533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability of two spermicides in five countries.
    Raymond E; Alvarado G; Ledesma L; Diaz S; Bassol S; Morales E; Fernandez V; Carlos G
    Contraception; 1999 Jul; 60(1):45-50. PubMed ID: 10549452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical study of the local contraceptive C-Film Lucchini].
    Porozhanova V; Bozhinova S; Khristova V
    Akush Ginekol (Sofiia); 1999; 38(3):54-6. PubMed ID: 10734685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.
    Niruthisard S; Roddy RE; Chutivongse S
    Lancet; 1992 Jun; 339(8806):1371-5. PubMed ID: 1350804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents.
    Zaneveld LJ; Waller DP; Ahmad N; Quigg J; Kaminski J; Nikurs A; De Jonge C
    J Androl; 2001; 22(3):481-90. PubMed ID: 11330649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
    Ward H; De La Court A; Kitchen V
    Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New spermicide: FHI developing propranolol.
    Netw Res Triangle Park N C; 1986; 7(2):2-3. PubMed ID: 12340619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
    Weir SS; Roddy RE; Zekeng L; Feldblum PJ
    Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative trial between two soft jelly capsules containing nonoxynol as spermicidal contraceptives.
    Bassol S; Recio R; de la Cruz DL
    Contraception; 1989 Apr; 39(4):409-18. PubMed ID: 2541967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute urinary retention secondary to urethral inflammation from a vaginal contraceptive suppository in a 17-year-old boy.
    Saborio DV; Kennedy WA; Hoke GP
    Urol Int; 1997; 58(2):128-30. PubMed ID: 9096278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of barrier methods of contraception with and without spermicide.
    Craig S; Hepburn S
    Contraception; 1982 Oct; 26(4):347-59. PubMed ID: 6759027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.